Latest Breaking News On - தேர்ந்தெடுக்கப்பட்டது நிதி தகவல் - Page 4 : comparemela.com

Ionis reports fourth quarter and full year 2020 financial results and recent business achievements Achieved 2020 financial guidance Webcast today, February 24, 2021, at 9:00 a.m. Eastern Time News provided by Share this article Share this article CARLSBAD, Calif., Feb. 24, 2021 /PRNewswire/ Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today reported its financial results for the fourth quarter of 2020 and recent business highlights. Last year, we laid out a bold new vision for the Company and took important steps towards our goal of becoming one of the most successful biotechnology companies. Key to our vision is our strategy to maximize the value of our pipeline by commercializing our wholly owned medicines. Our acquisition of Akcea was an important step in building our commercial capabilities while enabling us to further strengthen our organization, said Brett P. Monia, Ph.D., chief executive officer at Ionis. Last year, we also advanced our late-stage pipeline and expand

Elizabethl hougenIonis pharmaceuticals incPrnewswire ionis pharmaceuticals incIonis pharmaceuticalsAkcea therapeutics incFinancial resultsProducts highlightsSwedish orphan biovitrumRecent pipeline highlightsAkcea acquisitionRestructured europeanLoss attributableNoncontrolling interestIonis commonAkcea therapeuticsConsolidated statements